Ep0216 134 — Detroit, Michigan

Ep0216 134 is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Ep0216 134 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: CDKL5 Deficiency Disorder, Generalized Tonic Clonic Seizure, Epileptic Spasm.

Sponsors: Zogenix, Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ep0216 134?

Ep0216 134 has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ep0216 134 conducted?

Ep0216 134 has 1 clinical trials on record, with 1 currently active. Their work covers CDKL5 Deficiency Disorder, Generalized Tonic Clonic Seizure, Epileptic Spasm.

Is Ep0216 134 accredited by Crixeo Health?

Ep0216 134 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ep0216 134?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.